CASPR3 inhibitors are a class of chemical compounds designed to interfere with the activity of the Contactin Associated Protein-Like 3 (CASPR3), a member of the neurexin superfamily of proteins. CASPR3 is primarily involved in the regulation of neural cell interactions and axonal guidance, playing a role in the formation and maintenance of neural networks. These proteins are often localized at the paranodal regions of neurons, where they contribute to the organization and function of the myelin sheath, helping to facilitate rapid electrical signal transmission. CASPR3, like its related proteins, is involved in key structural and signaling processes in the nervous system, and inhibitors of CASPR3 can modulate these functions by disrupting specific interactions or signaling pathways related to neural connectivity.
The inhibition of CASPR3 activity can affect the molecular mechanisms that govern the proper localization of proteins at neuron-glial junctions and the integrity of synaptic structures. CASPR3 inhibitors, therefore, target the binding or functional domains of the CASPR3 protein, typically through small molecules or biological agents that interfere with its structure or its interactions with other proteins in the paranodal region. These inhibitors may bind to CASPR3 directly or interact with associated molecules, thereby altering the protein's role in neuronal organization. Research on CASPR3 inhibitors can provide insights into the broader mechanisms of neural cell communication and axonal function, shedding light on how such inhibitors might influence broader cellular processes related to neural network formation and maintenance. Understanding the precise chemical interactions that occur when CASPR3 is inhibited is crucial for advancing knowledge in neurobiology and cellular signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which can downregulate signaling pathways that may be involved in the regulation of CASPR3 expression or activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that acts similarly to LY294002, potentially altering signaling pathways that could indirectly affect CASPR3 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, which are upstream kinases in the MAPK/ERK pathway, potentially impacting transcription factors that regulate CASPR3 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAP kinase inhibitor that may alter inflammatory signaling pathways, potentially impacting the cellular context in which CASPR3 operates. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which may modify transcription factor activity affecting CASPR3 expression levels. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A γ-secretase inhibitor that can affect Notch signaling, potentially influencing neuronal development and CASPR3-related pathways. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
An inhibitor of the Hedgehog signaling pathway, which plays a role in neural development and could indirectly affect the expression or function of CASPR3. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can disrupt intracellular calcium signaling, potentially affecting calcium-dependent processes involving CASPR3. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
An inhibitor that modulates IP3 receptors and store-operated calcium entry, which may influence signaling pathways relevant to CASPR3. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
An inhibitor of myosin light chain kinase (MLCK), which may impact cytoskeletal dynamics and cellular processes associated with CASPR3. | ||||||